Correlation between plantar acceleration time and Doppler ultrasound with the ankle-brachial index in patients with peripheral arterial disease
DOI:
https://doi.org/10.18203/2349-2902.isj20242107Keywords:
Peripheral arterial disease, Angiosome, Inframalleolar Doppler ultrasound, Plantar acceleration time, Ankle brachial indexAbstract
Background: Due to the inaccuracy of the ankle-brachial index, especially in diabetic patients, different alternative strategies have been considered to evaluate patients with peripheral arterial disease, such as the measurement of plantar acceleration time with Doppler ultrasound. The use of plantar acceleration time was described, which consists of measuring the morphology of the wave produced by the time elapsed from the beginning of systole until reaching the maximum systolic peak, as represented on Doppler ultrasound. A morphological change in the wave could indicate some interaction due to the presence of resistance to flow and arterial ductility.
Methods: Sixty-five inframalleolar ultrasound studies were performed in patients with peripheral arterial disease. The acceleration time was calculated, and statistical analysis was conducted using linear regression and analysis of variance. The patients were correlated with the ankle-brachial index and among the studied inframalleolar arteries.
Results: Correlations were calculated with a non-parametric method: Spearman's correlation coefficient and it was identified that the plantar acceleration time was not significantly correlated with the ankle-brachial index. Probably due to the presence of non-compressible ankle-brachial indices, a significant correlation was found between the inframalleolar arteries studied.
Conclusions: The plantar acceleration time is a necessary complementary study for evaluating patients with peripheral arterial disease. It is essential to perform more inframalleolar ultrasound studies in patients for whom the ankle-brachial index is compressible and assessable, to establish a significant correlation within our population.
Metrics
References
Bolaños Martínez I, Chaves Chaves A, Gallón Vanegas L, Ibañez Morera M, López Barquero H. Enfermedad arterial periférica en miembros inferiores. Med Leg Costa Rica. 2019;36(1):84-90.
Oriol Toron PA, Badia Farre T, Romaguera Lliso A, Roda Diestro J. Sindrome metabolico y enfermedad arterial periferica: 2 enfermedades relacionadas. Endocinol Nutr. 2016;63(6):258-64.
Cortes Romero NM, Vargas Salazar BS, Gutierrez Romero A, Rios Morales R. Índice tobillo brazo y riesgo cardiovascular en pacientes con enfermedad hipertensiva de la Unidad de Medicina. Familiar 62. Revista Médica Sinergia. 2023;8(10):e1107.
Arévalo-Zamora C, Cifuentes JC, Plaza-Tenorio M, Cadavid-Velásquez LG, Ospina-Ospina S. Utilidad de la medición del tiempo de aceleración pedal en el diagnóstico de enfermedad arterial periférica. Angiología. 2022;74(6):271-7.
Sommerset J, Karmy-Jones R, Dally M. Plantar Acceleration Time: A Novel Technique to Evaluate Arterial Flow to the Foot. Ann Vasc Surg. 2019;60:308-14.
Ochoa-Ayón Bianca L, Quiroz-Villegas Martha E, Valdovinos-Estrada José A, Lozano-Corona Rodrigo, Sánchez-Nicolat Nora E, Martínez-Coria Tatzari, et al. Tiempo de aceleración plantar como factor predictivo para salvamento de extremidad. Rev Mex Angiol. 2022;50(4):126-33.
García García Y, Guerra Formigo L, Ailed Pérez P, Estévez Perera A, Acosta Cedeño A, Barnés Dominguez JA. Enfoque actual de la enfermedad arterial periférica asintomática en personas con diabetes melllitus. Rev Cubana Endocrinol. 2021;32(1):e220.
del Blanco Alonso MI, Gonzalez Fueyo MJ, Pena Cortez R, Alonso Argueso G, Sanz Pastor N, Vaquero Morilleo F. Es util el eco-Doppler portatil en el diagnostico de enfermedad arterial periferica? Estudio de validacion. Angiologia. 2012;64(5):193-8.
Ciancaglini C. El Laboratorio Vascular Periférico: requisitos y Conceptos Básicos. Rev Costarric Cardiol. 2004;6(3):21-30.
Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: A meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51:395-403.